Local treatment of breast cancer liver metastasis
R Bale, D Putzer, P Schullian - Cancers, 2019 - mdpi.com
Breast cancer represents a leading cause of death worldwide. Despite the advances in
systemic therapies, the prognosis for patients with breast cancer liver metastasis (BCLM) …
systemic therapies, the prognosis for patients with breast cancer liver metastasis (BCLM) …
The FUS/circEZH2/KLF5/feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition
P Liu, Z Wang, X Ou, P Wu, Y Zhang, S Wu, X Xiao… - Molecular cancer, 2022 - Springer
Background Metastasis of breast cancer have caused the majority of cancer-related death
worldwide. The circRNAs are associated with tumorigenesis and metastasis in breast cancer …
worldwide. The circRNAs are associated with tumorigenesis and metastasis in breast cancer …
Cryoablation and immunotherapy: an overview of evidence on its synergy
BM Aarts, EG Klompenhouwer, SL Rice, F Imani… - Insights into …, 2019 - Springer
Cancer cells can escape the immune system by different mechanisms. The evasion of
cancer cells from immune surveillance is prevented by immune checkpoint inhibitors …
cancer cells from immune surveillance is prevented by immune checkpoint inhibitors …
The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin
Background Metastasis causes the majority of cancer-related deaths worldwide. Increasing
studies have revealed that circRNAs are associated with the carcinogenesis and metastasis …
studies have revealed that circRNAs are associated with the carcinogenesis and metastasis …
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice
Immunomodulators that remodel the tumor immunosuppressive microenvironment have
been combined with anti–programmed death 1 (α-PD1) or anti–programmed death ligand 1 …
been combined with anti–programmed death 1 (α-PD1) or anti–programmed death ligand 1 …
Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis
To investigate the effects of age at diagnosis on metastatic breast cancer and patients'
prognosis, we collected patient data from the Surveillance, Epidemiology, and End Results …
prognosis, we collected patient data from the Surveillance, Epidemiology, and End Results …
Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
H Stamm, L Oliveira-Ferrer, EM Grossjohann… - …, 2019 - Taylor & Francis
Immune checkpoints are intensively investigated as targets in cancer therapy. T-cell
immunoreceptor with immunoglobulin (Ig) and ITIM domains (TIGIT) and its ligand poliovirus …
immunoreceptor with immunoglobulin (Ig) and ITIM domains (TIGIT) and its ligand poliovirus …
Engineering an active immunotherapy for personalized cancer treatment and prevention of recurrence
Breast cancer has been shown to be resistant to immunotherapies. To overcome this
challenge, we developed an active immunotherapy for personalized treatment based on a …
challenge, we developed an active immunotherapy for personalized treatment based on a …
Clinical relevancy of circulating tumor cells in breast cancer: epithelial or mesenchymal characteristics, single cells or clusters?
I Fridrichova, L Kalinkova, S Ciernikova - International Journal of …, 2022 - mdpi.com
Metastatic breast cancer (MBC) is typically an incurable disease with high mortality rates;
thus, early identification of metastatic features and disease recurrence through precise …
thus, early identification of metastatic features and disease recurrence through precise …
An ontology-guided semantic data integration framework to support integrative data analysis of cancer survival
Background Cancer is the second leading cause of death in the United States, exceeded
only by heart disease. Extant cancer survival analyses have primarily focused on individual …
only by heart disease. Extant cancer survival analyses have primarily focused on individual …